View Full Paper

Corporate Governance for Pharmaceutical Firms: Ethical Considerations | Post-Pandemic Lessons

• Finance
• Epidemiology
• IoT

Abstract

This research proposal investigates “Corporate Governance for Pharmaceutical Firms: Ethical Considerations | Post-Pandemic Lessons” using a randomized controlled trial design. Through a economic lens, the analysis integrates multi-source data to derive an actionable roadmap for researchers and practitioners.